Neonatal Linear Immunoglobulin A Bullous Dermatosis: A Critical Case Recovering after Prompt Recognition, Intensive Management, and Breastfeeding Interruption - A Case Report.

Détails

ID Serval
serval:BIB_701D6B438C54
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Neonatal Linear Immunoglobulin A Bullous Dermatosis: A Critical Case Recovering after Prompt Recognition, Intensive Management, and Breastfeeding Interruption - A Case Report.
Périodique
Neonatology
Auteur⸱e⸱s
Papasavva D., Dosso L., Morren M.A., Fontao L., Bruschi L., Gorostidi F., Ferry T., Guenova E., Fischer Fumeaux C.J., Joye S.
ISSN
1661-7819 (Electronic)
ISSN-L
1661-7800
Statut éditorial
In Press
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: aheadofprint
Résumé
Neonatal linear immunoglobulin A (IgA) bullous dermatosis (NLABD) is a rare, life-threatening, mucocutaneous bullous disorder. The pathogenesis and optimal treatment remain poorly defined and raise critical clinical challenges.
We present a case of a full-term female infant with severe cutaneous and respiratory symptoms due to NLABD. Diagnosis was confirmed by immunofluorescence on the infant's skin biopsy, while IgAs directed against the basement membrane of the skin and mucosa were identified in the mother's milk. The infant fully recovered after nearly 8 weeks of intensive multidisciplinary care, including non-invasive ventilation, nutritional support, wound care, systemic corticoid treatment, and breastfeeding discontinuation.
This case underscores the importance of timely adequate diagnosis and management of this rare and serious condition. Moreover, it adds novel evidence documenting the presence of pathogenic IgAs in breastmilk.
Mots-clé
Blister, Breastmilk, Case report, Corticosteroids, Immunoglobulin A
Pubmed
Web of science
Open Access
Oui
Création de la notice
20/09/2024 15:07
Dernière modification de la notice
31/10/2024 7:13
Données d'usage